COX-2 Inhibition Prevents Insulin-Dependent Diabetes in Low-Dose Streptozotocin-Treated Mice
- 5 July 2000
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 273 (2), 699-704
- https://doi.org/10.1006/bbrc.2000.2959
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The Cyclooxygenase-2 Inhibitor NS-398 Ameliorates Ischemic Brain Injury in Wild-Type Mice but not in Mice with Deletion of the Inducible Nitric Oxide Synthase GeneJournal of Cerebral Blood Flow & Metabolism, 1999
- Specific NF‐κB blockade selectively inhibits tumour necrosis factor‐α‐induced COX‐2 but not constitutive COX‐1 gene expression in HT‐29 cellsImmunology, 1998
- Protection from experimental autoimmune diabetes in the non‐obese diabetic mouse with soluble interleukin‐1 receptorEuropean Journal of Immunology, 1994
- Interleukin-1 Receptor Antagonist Prevents Low-Dose Streptozotocin-Induced Diabetes in MiceBiochemical and Biophysical Research Communications, 1994
- Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives.JCI Insight, 1994
- Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB ratsFEBS Letters, 1993
- Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitorLife Sciences, 1991
- Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in miceBiochemical and Biophysical Research Communications, 1991
- A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic isletsJournal of Autoimmunity, 1989
- Streptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes MellitusScience, 1976